Literature DB >> 26827909

Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients.

P Zaenker1, E S Gray2, M R Ziman3.   

Abstract

A link between autoimmune responses and cancer via autoantibodies was first described in the 1950s. Since, autoantibodies have been studied for their potential use as cancer biomarkers, however the exact causes of their production remain to be elucidated. This review summarizes current theories of the causes of autoantibody production in cancer, namely: 1) defects in tolerance and inflammation, 2) changes in protein expression levels, 3) altered protein structure, and 4) cellular death mechanisms. We also highlight the need for further research into this field to improve our understanding of autoantibodies as biomarkers for cancer development and progression.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibody; Autoantibody production; Biomarker; Cancer; Humoral immune response; Immune surveillance

Mesh：

Substances：

Year:  2016        PMID： 26827909     DOI： 10.1016/j.autrev.2016.01.017

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN： 1568-9972            Impact factor:   9.754


  65 in total

1.  High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids.

Authors:  Frank Antony; Cecilia Deantonio; Diego Cotella; Maria Felicia Soluri; Olga Tarasiuk; Francesco Raspagliesi; Fulvio Adorni; Silvano Piazza; Yari Ciani; Claudio Santoro; Paolo Macor; Delia Mezzanzanica; Daniele Sblattero
Journal:  Oncoimmunology       Date:  2019-06-04       Impact factor: 8.110

2.  Region-specific permeability of the blood-brain barrier upon pericyte loss.

Authors:  Roberto Villaseñor; Basil Kuennecke; Laurence Ozmen; Michelle Ammann; Christof Kugler; Fiona Grüninger; Hansruedi Loetscher; Per-Ola Freskgård; Ludovic Collin
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-01       Impact factor: 6.200

Review 3.  Cancer Self-Defense: An Immune Stealth.

Authors:  Kosei Nakajima; Pratima Nangia-Makker; Victor Hogan; Avraham Raz
Journal:  Cancer Res       Date:  2017-08-24       Impact factor: 12.701

Review 4.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

5.  Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.

Authors:  Renée T Fortner; Helena Schock; Charlotte Le Cornet; Anika Hüsing; Allison F Vitonis; Theron S Johnson; Raina N Fichorova; Titilayo Fashemi; Hidemi S Yamamoto; Anne Tjønneland; Louise Hansen; Kim Overvad; Marie-Christine Boutron-Ruault; Marina Kvaskoff; Gianluca Severi; Heiner Boeing; Antonia Trichopoulou; Eleni-Maria Papatesta; Carlo La Vecchia; Domenico Palli; Sabina Sieri; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; N Charlotte Onland-Moret; Petra H Peeters; H B As Bueno-de-Mesquita; Elisabete Weiderpass; J Ramón Quirós; Eric J Duell; Maria-Jose Sánchez; Carmen Navarro; Eva Ardanaz; Nerea Larrañaga; Björn Nodin; Karin Jirström; Annika Idahl; Eva Lundin; Kay-Tee Khaw; Ruth C Travis; Marc Gunter; Mattias Johansson; Laure Dossus; Melissa A Merritt; Elio Riboli; Kathryn L Terry; Daniel W Cramer; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2017-12-11       Impact factor: 7.396

6.  The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma.

Authors:  Asmaa M El-Rasikh; Haithem A M Farghali; Hisham A Abdelrahman; Mostafa Elgaffary; Shaymaa Abdelmalek; Ibrahim A Emam; Magdy A Ghoneim; Salah A Selim
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

7.  Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Jiqiang He; Xinqi Fang; Mingming Han
Journal:  Front Genet       Date:  2021-05-24       Impact factor: 4.599

8.  Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.

Authors:  Wei-Lei Yang; Zhen Lu; Jing Guo; Bryan M Fellman; Jing Ning; Karen H Lu; Usha Menon; Makoto Kobayashi; Samir M Hanash; Joseph Celestino; Steven J Skates; Robert C Bast
Journal:  Cancer       Date:  2019-11-12       Impact factor: 6.860

9.  Autoantibody Landscape in Patients with Advanced Prostate Cancer.

Authors:  William S Chen; Winston A Haynes; Rebecca Waitz; David Y Oh; John C Shon; Felix Y Feng; Kathy Kamath; Agustin Vega-Crespo; Raunak Shrestha; Minlu Zhang; Adam Foye; Ignacio Baselga Carretero; Ivan Perez Garcilazo; Meng Zhang; Shuang G Zhao; Martin Sjöström; David A Quigley; Jonathan Chou; Tomasz M Beer; Matthew Rettig; Martin Gleave; Christopher P Evans; Primo Lara; Kim N Chi; Robert E Reiter; Joshi J Alumkal; Alan Ashworth; Rahul Aggarwal; Eric J Small; Patrick S Daugherty; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2020-09-23       Impact factor: 12.531

10.  Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays.

Authors:  María González-González; José María Sayagués; Luis Muñoz-Bellvís; Carlos Eduardo Pedreira; Marcello L R de Campos; Jacinto García; José Antonio Alcázar; Patrick F Braz; Breno L Galves; Luis Miguel González; Oscar Bengoechea; María Del Mar Abad; Juan Jesús Cruz; Lorena Bellido; Emilio Fonseca; Paula Díez; Pablo Juanes-Velasco; Alicia Landeira-Viñuela; Quentin Lecrevisse; Enrique Montalvillo; Rafael Góngora; Oscar Blanco; José Manuel Sánchez-Santos; Joshua LaBaer; Alberto Orfao; Manuel Fuentes
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.